Speaker: Joshua Sabari

0:00:53

The future of HER2-directed therapies in non-small cell lung cancer

0:00:32

How important is NGS for biomarker testing in NSCLC?

0:01:37

Treatment strategies for KRAS-mutant NSCLC with co-mutations

0:00:55

What are the latest updates in non-G12C KRAS allele-specific inhibition?

0:00:57

PROs in the Beamion LUNG-1 of zongertinib in HER2-mutated NSCLC

0:02:07

PAPILLON: amivantamab plus chemotherapy in NSCLC with EGFR exon 20 insertions

0:03:17

KRYSTAL-1: activity of adagrasib in KRASG12m NSCLC with untreated CNS metastases

0:01:34

PROs in PAPILLON trial: amivantamab + chemo for EGFR Exon 20 NSCLC

0:16:22

Novel combinations in EGFR positive advanced NSCLC

0:00:48

Assessing EFGR TKIs in patients with wild-type EFGR NSCLC

0:01:18

The importance of understanding the patient perspective in evaluating treatment efficacy

0:04:01

What are the latest developments in KRAS-mutant NSCLC?

0:01:00

Beamion LUNG-1: zongertinib for pre-treated HER2-mutant NSCLC

0:11:42

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC

0:01:19

LY3537982: a novel KRAS G12C inhibitor in solid tumors

0:01:05

Advances in managing KRASG12C- and EGFR-mutated NSCLC

0:16:45

Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve EGFRm NSCLC

0:01:31

ASCO 2023: highlights in non-small cell lung cancer

1:32:22

Annual Lung Cancer Awareness Program 2019

0:00:39

ASCO 2022: Highlights in lung cancer

1:07:20

Annual 2020 Lung Cancer Awareness Program

0:00:12

Rashmika Hook Step For Saami Saami Song | #Pushpa | #AlluArjun | #DSP | Sukumar | #Shorts

0:00:11

Lighthouse in Stormy Seas! Waves Crashing on Lighthouse! #scaryocean #storm #WavesCrashing #Waves